Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04205396 · ClinicalTrials.gov registry record · NA
CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis
A NA study of Caregivers, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
- 1
- Study location
NCT04205396: Completed NA study of Caregivers, sponsored by University of Michigan.
NCT04205396 is a NA study of Caregivers that has completed, run by University of Michigan. The registered enrollment target is 87 participants, roughly in line with the 95-participant average among 15 other Caregivers trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04205396, a NA study of Caregivers, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to enroll caretakers of patients with decompensated cirrhosis to determine if written emotional disclosure or resilience training interventions reduce distress and burden among primary informal caregivers. Caretakers that meet eligibility will complete baseline assessments in person, or if necessary, over the phone and be randomized to be in one of three arms of this study. Materials specific to each study arm will be mailed to the caretakers home along with instructions. Overall, the study will take approximately 2 months and a qualitative interview will also be completed around 3-6 months post-baseline.
Primary Outcome
The short form of the ZBI is a validated short 12-item questionnaire measuring perceived burden associated with care giving. Participants rate each item on a 5-point scale ranging from 0 (never) to 4 (nearly always) the range of possible score is 0 (less burden) to 48 (more burden).
Conditions Studied
Interventions
- OTHER No treatment
- BEHAVIORAL Written emotional disclosure
- BEHAVIORAL Resilience training
Study Locations (1)
Michigan
- The University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2020-02-10 |
| Est. Completion | 2022-03-22 |
| Phase | NA |
What the finished NCT04205396 record still lists
NCT04205396 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, roughly in line with the 95-participant average among 15 other Caregivers trials with a reported enrollment target.
The record links to 1 condition, with Caregivers appearing as the primary indexed condition, and to 3 interventions - of which No treatment is the first listed.
NCT04205396 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04205396 about?
NCT04205396 is a clinical study titled "CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis". The goal of this study is to enroll caretakers of patients with decompensated cirrhosis to determine if written emotional disclosure or resilience training interventions reduce distress and burden among primary informal caregivers. Caretakers that meet eligibility will complete baseline assessments...
What is the current status of trial NCT04205396?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2020-02-10. Estimated completion is 2022-03-22.
What conditions does trial NCT04205396 study?
This clinical trial studies the following conditions: Caregivers.
What interventions are being tested in trial NCT04205396?
The interventions under investigation include: No treatment (OTHER), Written emotional disclosure (BEHAVIORAL), Resilience training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04205396?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04205396 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregivers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04205396's enrollment target sits among peer trials
87 6th of 15 higher than 10 of 15 other Caregivers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Caregivers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
Pilot Study of Hospital GamePlan4Care
RECRUITING · NA
-
Cereset Research for Caregivers
RECRUITING · NA
-
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
RECRUITING · NA
-
Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest
RECRUITING · NA
-
Supporting Care Partners' Well-Being With Artificial Intelligence (AI) Chatbots
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI